Another controversy over futile care in Texas


Chris Dunn in hospital bed before Christmas   

Medical ethicists have clashed over the death of Chris Dunn, a Texan man at the centre of an end-of-life care legal battle.

Dunn, 46, died late last month, following a year-long battle with apparent pancreatic cancer. Certain members of his family were petitioning a court to mandate the continuation of life-sustaining treatment. A medical ethics committee at Houston Methodist Hospital, acting on advice from one of Dunn’s doctors, deemed ANH to be inappropriate and decided to allow his doctor to discontinue life-sustaining treatment.

Some of the details of the case remain unclear. It is perhaps best merely to quote the differing opinions that have been offered following Dunn’s death.

In an essay in The Public Discourse earlier this month, paediatrician Phillip Hawley Jr. argued that the decision of the hospital to Dunn’s life-sustaining treatment was tantamount to ‘death by committee’:

“Having participated in many treatment discussions on behalf of terminally ill patients, I will readily acknowledge that patients and families sometimes have unrealistic hopes for a cure. However, acknowledging this possibility does not redeem a badly flawed law or vindicate a morally corrupt decision. In deciding to withdraw life-sustaining treatment from an alert and cognizant patient who so obviously wanted to continue living, the hospital and its ethics committee stole from him the two most fundamental rights enumerated in our Constitution: life and liberty.”

Hawley argues that there is evidence to suggest that Dunn was still capable of rational decision-making, and that, in any event, it was unjust for the hospital to attempt to override the wishes of his family members who wanted ANH to continue.

“Relative strangers with little or no knowledge of his values and beliefs weighed his “quality of life” and decided that he no longer deserved to live…

“On many occasions, I have watched anguished parents struggle to discern what is in the best interest of their terminally ill child—a child they have known since birth…But, somehow, we are to believe that these committee members were able to deduce existential truths about what was in Chris Dunn’s best interest?”

Dr. Beverly B. Nuckols, a family physician from Texas, and Deirdre Cooper, a public policy analyst at Texas Alliance for Life, penned a terse reply. Cooper and Nuckols suggest that, on the evidence available, it seems that the decision to discontinue Dunn’s ANH might have been justified. They take issue with what they see as the Hawley’s attribution of murderous intentions to the hospital staff and ethics committee.

“This is not simply a case of a hospital or a doctor versus the patient and his family. Rather, this is a case of an incapacitated patient who was terminally ill, whose parents disagreed about the best course of treatment, and whose doctors believed that life-sustaining treatment was causing suffering, as is plainly evident from court documents

“It is plausible that the doctors had good reasons to believe that the pancreatic cancer was untreatable. They may have believed that attempts to maintain the status quo would be medically ineffective, would not save his life, and would increase physical pain and bodily damage while possibly hastening death…”

The case of Chris Dunn is another controversy caused by Texas’s Advance Directives Act (or futile care law), which allows doctors to discontinue life-sustaining treatment ten days after giving written notice if life-sustaining treatment is deemed futile. 




MORE ON THESE TOPICS | futile care, Texas

This article is published by Xavier Symons and BioEdge under a Creative Commons licence. You may republish it or translate it free of charge with attribution for non-commercial purposes following these guidelines. If you teach at a university we ask that your department make a donation. Commercial media must contact us for permission and fees. Some articles on this site are published under different terms.

comments powered by Disqus
 
 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

MOST READ

 Best of the web